Portfolio company
Scailyte
Switzerland · £6.3m raised
Raised
£6.3m
Latest stage
Series A
Rounds recorded
1
Backed by
1 investor
Sectors
About
This company develops artificial intelligence software for single-cell data analysis and biomarker discovery for pharmaceutical, clinical and academic research customers.
SourceFunding history · 1
Similar companies
1Cell.Ai
The company develops single-cell multi-omic analysis platforms for oncology researchers and drug developers to monitor therapies, discover biomarkers, and study tumour heterogeneity.
Phenomic AI
This company develops a machine learning platform for drug discovery through cell imaging and single-cell RNA sequencing for pharmaceutical and biotechnology partners.
Nygen
This company develops cloud-based data platforms that use artificial intelligence to analyse and interpret single-cell genomic datasets for pharmaceutical and academic research teams.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
StratifAI
This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.
DropPrint Genomics
This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.
Deepcell
Deepcell develops an artificial intelligence-powered imaging and sorting platform for single-cell morphology analysis, serving life sciences researchers, diagnostic labs, and pharmaceutical companies.
QuirieGen
This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.
